SUNESIS PHARMACEUTICALS INC — Form D
SUNESIS PHARMACEUTICALS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-14. The offering totals $28.5M, of which $28.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-07-14
- Form: D
- Accession: 0001061027-10-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $28.5M
- Amount sold: $28.5M
- Investors: 18
- Date of first sale: 2010-06-30
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-144882
Issuer
- Name: SUNESIS PHARMACEUTICALS INC
- CIK: 0001061027
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 395 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-266-3500
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Matthew K Fust | Director | Menlo Park, CA |
| Ed K Hurwitz | Director | San Francisco, CA |
| Helen Susan Kim | Director | South San Francisco, CA |
| Dayton K Misfeldt | Director | San Francisco, CA |
| Homer L Pearce | Director | Indianapolis, IN |
| David C Stump | Director | Rockville, MD |
| Daniel N Jr Swisher | Director | South San Francisco, CA |
| JAMES W YOUNG | Director | HAYWARD, CA |
| Eric H Bjerkholt | Executive Officer | Brisbane, CA |
| Steven H Ketchum | Executive Officer | South San Francisco, CA |
| Daniel N Jr Swisher | Executive Officer | South San Francisco, CA |
| Ed Hurwitz | Director | San Diego, CA |
| Dayton Misfeldt | Director | Waltham, MA |
| Eric H Bjerholt | Executive Officer | South San Francisco, CA |
| Steven B Ketchum | Executive Officer | South San Francisco, CA |
Other filings by this issuer (1)
More